NPCE vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

NPCE

45.8
AI Score
VS
LUNG Wins

LUNG

56.3
AI Score

Investment Advisor Scores

NPCE

46score
Recommendation
HOLD

LUNG

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NPCE LUNG Winner
Forward P/E 0 28.3286 Tie
PEG Ratio 0 0 Tie
Revenue Growth -2.0% -8.7% NPCE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 45.8/100 56.3/100 LUNG
Profit Margin -21.7% -60.1% NPCE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NPCE 1M: -18.3% · 3M: -23.5% LUNG 1M: +10.9% · 3M: +27.3%

Current Technical Phase

NPCE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.6%), weak momentum, RSI 30

RSI (14): 29.6 · Price: $12.89

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 65

RSI (14): 64.7 · Price: $1.63

Fundamentals Snapshot

Metric NPCE LUNG
Market Cap
Forward P/E -43.9 -1.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.1%
Gross Margin 0.8% 0.8%
Operating Margin -0.3% -0.6%
EPS -0.65 -1.30
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.